Concepts (338)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastric Bypass | 8 | 2022 | 824 | 1.770 |
Why?
|
| Obesity, Morbid | 5 | 2022 | 1298 | 1.100 |
Why?
|
| Fish Oils | 15 | 2009 | 483 | 1.100 |
Why?
|
| Weight Loss | 11 | 2022 | 2721 | 1.040 |
Why?
|
| S Phase | 8 | 2007 | 424 | 0.910 |
Why?
|
| Weight Gain | 3 | 2021 | 2360 | 0.860 |
Why?
|
| Hyperphagia | 1 | 2021 | 139 | 0.730 |
Why?
|
| Phentermine | 1 | 2020 | 31 | 0.700 |
Why?
|
| Anti-Obesity Agents | 2 | 2021 | 240 | 0.680 |
Why?
|
| Obesity | 15 | 2021 | 13092 | 0.560 |
Why?
|
| Dietary Carbohydrates | 1 | 2021 | 896 | 0.540 |
Why?
|
| Insulin | 11 | 2021 | 6607 | 0.530 |
Why?
|
| Metabolic Diseases | 1 | 2021 | 684 | 0.480 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2016 | 374 | 0.440 |
Why?
|
| Insulin Resistance | 8 | 2021 | 3987 | 0.410 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2017 | 372 | 0.410 |
Why?
|
| Insulin-Secreting Cells | 2 | 2019 | 898 | 0.390 |
Why?
|
| Bariatric Surgery | 1 | 2021 | 1002 | 0.360 |
Why?
|
| Fructose | 1 | 2012 | 284 | 0.350 |
Why?
|
| Endocrinology | 1 | 2016 | 443 | 0.350 |
Why?
|
| Intestinal Neoplasms | 1 | 2012 | 314 | 0.340 |
Why?
|
| DNA Replication | 3 | 2002 | 1426 | 0.320 |
Why?
|
| G1 Phase | 3 | 2007 | 403 | 0.320 |
Why?
|
| Muscles | 10 | 1994 | 1581 | 0.310 |
Why?
|
| Glycolysis | 1 | 2012 | 837 | 0.300 |
Why?
|
| Dietary Fats | 8 | 2019 | 2001 | 0.290 |
Why?
|
| Cell Cycle | 5 | 2001 | 2930 | 0.280 |
Why?
|
| Carcinoma 256, Walker | 5 | 1995 | 37 | 0.280 |
Why?
|
| Postoperative Complications | 2 | 2021 | 15829 | 0.270 |
Why?
|
| Lipids | 3 | 2016 | 3328 | 0.250 |
Why?
|
| Tumor Necrosis Factor-alpha | 9 | 1995 | 4351 | 0.240 |
Why?
|
| Interleukin-1 | 6 | 1995 | 1252 | 0.220 |
Why?
|
| Docosahexaenoic Acids | 2 | 2001 | 914 | 0.220 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2012 | 2843 | 0.220 |
Why?
|
| Bromodeoxyuridine | 5 | 2002 | 310 | 0.220 |
Why?
|
| Mammary Neoplasms, Experimental | 3 | 1995 | 497 | 0.210 |
Why?
|
| Electronic Health Records | 1 | 2020 | 4881 | 0.210 |
Why?
|
| Endotoxins | 3 | 1995 | 519 | 0.200 |
Why?
|
| Replication Origin | 1 | 2002 | 77 | 0.200 |
Why?
|
| Leucine | 11 | 1995 | 547 | 0.200 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 2002 | 133 | 0.200 |
Why?
|
| Parenteral Nutrition, Total | 8 | 1995 | 304 | 0.200 |
Why?
|
| Glucose Clamp Technique | 1 | 2021 | 262 | 0.180 |
Why?
|
| Cell Division | 7 | 2002 | 4473 | 0.180 |
Why?
|
| Electron Transport | 1 | 2021 | 211 | 0.180 |
Why?
|
| Biomedical Research | 1 | 2016 | 3464 | 0.180 |
Why?
|
| Cytoplasm | 2 | 2021 | 1505 | 0.170 |
Why?
|
| Triglycerides | 8 | 2019 | 2452 | 0.170 |
Why?
|
| Flow Cytometry | 8 | 2002 | 5893 | 0.170 |
Why?
|
| Practice Guidelines as Topic | 2 | 2016 | 7436 | 0.160 |
Why?
|
| Rats, Inbred Strains | 15 | 1992 | 2085 | 0.160 |
Why?
|
| Glutathione | 1 | 2021 | 589 | 0.160 |
Why?
|
| Proteins | 12 | 2017 | 6006 | 0.160 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2022 | 12254 | 0.150 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2001 | 661 | 0.140 |
Why?
|
| Protein-Energy Malnutrition | 1 | 2017 | 189 | 0.140 |
Why?
|
| Fungal Proteins | 1 | 2001 | 906 | 0.130 |
Why?
|
| Glucose | 6 | 2012 | 4350 | 0.130 |
Why?
|
| Nutritional Sciences | 1 | 2017 | 148 | 0.130 |
Why?
|
| Rats | 29 | 1995 | 23749 | 0.130 |
Why?
|
| Oxidation-Reduction | 1 | 2021 | 2226 | 0.120 |
Why?
|
| Postoperative Period | 1 | 2020 | 1826 | 0.120 |
Why?
|
| Pancreatic Neoplasms | 1 | 2012 | 5446 | 0.120 |
Why?
|
| Treatment Failure | 1 | 2021 | 2660 | 0.120 |
Why?
|
| Splanchnic Circulation | 2 | 1992 | 122 | 0.110 |
Why?
|
| Humans | 45 | 2022 | 767715 | 0.110 |
Why?
|
| Documentation | 1 | 2020 | 915 | 0.110 |
Why?
|
| Retrospective Studies | 7 | 2022 | 81689 | 0.110 |
Why?
|
| Protein Kinases | 1 | 2001 | 1611 | 0.110 |
Why?
|
| Adult | 24 | 2021 | 223562 | 0.100 |
Why?
|
| Vitamin D | 1 | 2007 | 3312 | 0.100 |
Why?
|
| Toxemia | 1 | 1992 | 14 | 0.100 |
Why?
|
| Neoplasm Proteins | 4 | 1993 | 3600 | 0.100 |
Why?
|
| Female | 25 | 2021 | 396999 | 0.100 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2012 | 57 | 0.100 |
Why?
|
| Male | 47 | 2021 | 364584 | 0.100 |
Why?
|
| Corn Oil | 2 | 2002 | 29 | 0.100 |
Why?
|
| Middle Aged | 13 | 2021 | 223408 | 0.100 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2012 | 126 | 0.100 |
Why?
|
| Dietary Proteins | 5 | 1986 | 960 | 0.100 |
Why?
|
| Safflower Oil | 5 | 1995 | 29 | 0.100 |
Why?
|
| Sarcoma, Experimental | 1 | 1991 | 116 | 0.090 |
Why?
|
| Lactates | 1 | 1992 | 399 | 0.090 |
Why?
|
| Adipose Tissue | 2 | 2021 | 3327 | 0.090 |
Why?
|
| Zinc | 7 | 1995 | 676 | 0.090 |
Why?
|
| Plant Proteins | 2 | 1983 | 376 | 0.090 |
Why?
|
| Neoplasm Transplantation | 6 | 1995 | 2012 | 0.090 |
Why?
|
| Cluster Analysis | 2 | 2016 | 2731 | 0.090 |
Why?
|
| Time Factors | 10 | 2018 | 40206 | 0.090 |
Why?
|
| Caloric Restriction | 1 | 2013 | 302 | 0.090 |
Why?
|
| Fibroblasts | 1 | 2001 | 4168 | 0.090 |
Why?
|
| Nitrogen | 5 | 1989 | 344 | 0.090 |
Why?
|
| Fatty Acids, Omega-3 | 3 | 2002 | 1399 | 0.090 |
Why?
|
| Diet, Carbohydrate-Restricted | 1 | 2013 | 263 | 0.090 |
Why?
|
| Indomethacin | 2 | 2001 | 323 | 0.090 |
Why?
|
| Analysis of Variance | 3 | 2016 | 6227 | 0.090 |
Why?
|
| Overweight | 1 | 2021 | 2449 | 0.090 |
Why?
|
| Maternal-Fetal Exchange | 2 | 1989 | 454 | 0.080 |
Why?
|
| Muscle Proteins | 3 | 1992 | 1165 | 0.080 |
Why?
|
| Phenylpropanolamine | 1 | 1989 | 15 | 0.080 |
Why?
|
| Carrier Proteins | 2 | 2001 | 4936 | 0.080 |
Why?
|
| Cell Cycle Proteins | 1 | 2001 | 3441 | 0.080 |
Why?
|
| Postoperative Care | 1 | 2016 | 1480 | 0.080 |
Why?
|
| Cyclooxygenase Inhibitors | 2 | 2001 | 361 | 0.080 |
Why?
|
| Liver | 13 | 1995 | 7586 | 0.080 |
Why?
|
| Lipoproteins, HDL | 1 | 2013 | 680 | 0.080 |
Why?
|
| Colonic Neoplasms | 1 | 2000 | 2536 | 0.080 |
Why?
|
| Embryonic and Fetal Development | 1 | 1989 | 420 | 0.080 |
Why?
|
| Peptide Hydrolases | 1 | 1991 | 610 | 0.080 |
Why?
|
| Recurrence | 1 | 2021 | 8505 | 0.070 |
Why?
|
| Preoperative Period | 1 | 2010 | 564 | 0.070 |
Why?
|
| Mitochondria | 1 | 2021 | 3681 | 0.070 |
Why?
|
| Calcitriol | 1 | 2009 | 303 | 0.070 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2012 | 1168 | 0.070 |
Why?
|
| Body Weight | 9 | 2021 | 4629 | 0.070 |
Why?
|
| Adiponectin | 1 | 2013 | 1117 | 0.070 |
Why?
|
| Eating | 3 | 2007 | 1542 | 0.070 |
Why?
|
| Sarcoma, Yoshida | 3 | 1992 | 11 | 0.070 |
Why?
|
| Interleukin-2 | 1 | 1994 | 1895 | 0.070 |
Why?
|
| Brachial Artery | 2 | 2008 | 373 | 0.070 |
Why?
|
| Cholesterol, HDL | 1 | 2013 | 1820 | 0.070 |
Why?
|
| Dietary Supplements | 1 | 2019 | 3446 | 0.070 |
Why?
|
| Pregnancy, Animal | 1 | 1987 | 124 | 0.070 |
Why?
|
| Joint Diseases | 1 | 2010 | 461 | 0.070 |
Why?
|
| RNA, Messenger | 1 | 2021 | 12798 | 0.070 |
Why?
|
| Animals | 37 | 2017 | 169178 | 0.060 |
Why?
|
| Body Mass Index | 5 | 2013 | 13053 | 0.060 |
Why?
|
| Mathematics | 3 | 1994 | 704 | 0.060 |
Why?
|
| Blood Pressure | 3 | 1993 | 8539 | 0.060 |
Why?
|
| Glucose Tolerance Test | 3 | 2019 | 1181 | 0.060 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 39340 | 0.060 |
Why?
|
| Cell Line, Tumor | 3 | 2012 | 17105 | 0.060 |
Why?
|
| Apoptosis | 1 | 2000 | 9520 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 9 | 1995 | 8117 | 0.060 |
Why?
|
| Kinetics | 9 | 1995 | 6329 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 3 | 2000 | 6108 | 0.060 |
Why?
|
| Prostatic Neoplasms | 1 | 2007 | 11097 | 0.060 |
Why?
|
| Communicable Diseases | 1 | 1992 | 872 | 0.060 |
Why?
|
| Fatty Acids, Unsaturated | 2 | 2001 | 542 | 0.050 |
Why?
|
| Infusions, Intravenous | 3 | 1994 | 2227 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2001 | 9614 | 0.050 |
Why?
|
| Risk Factors | 4 | 2021 | 74936 | 0.050 |
Why?
|
| Carbon Radioisotopes | 5 | 1991 | 567 | 0.050 |
Why?
|
| Dyslipidemias | 1 | 2010 | 873 | 0.050 |
Why?
|
| Cell Extracts | 1 | 2002 | 134 | 0.050 |
Why?
|
| Cell-Free System | 1 | 2002 | 339 | 0.050 |
Why?
|
| Diet | 7 | 1992 | 8089 | 0.050 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 1983 | 360 | 0.050 |
Why?
|
| Hypertension | 3 | 2010 | 8616 | 0.050 |
Why?
|
| C-Reactive Protein | 1 | 2013 | 3857 | 0.050 |
Why?
|
| Fasting | 4 | 1995 | 1609 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2001 | 10754 | 0.050 |
Why?
|
| Quality of Health Care | 1 | 2016 | 4308 | 0.050 |
Why?
|
| Oxidative Stress | 1 | 2012 | 3140 | 0.050 |
Why?
|
| Butylated Hydroxytoluene | 1 | 2000 | 8 | 0.050 |
Why?
|
| Retinoblastoma-Binding Protein 1 | 1 | 2001 | 138 | 0.050 |
Why?
|
| Transcription Factor DP1 | 1 | 2001 | 136 | 0.050 |
Why?
|
| Vasodilation | 3 | 2013 | 970 | 0.040 |
Why?
|
| HT29 Cells | 1 | 2001 | 187 | 0.040 |
Why?
|
| DNA | 5 | 2002 | 7212 | 0.040 |
Why?
|
| E2F1 Transcription Factor | 1 | 2001 | 182 | 0.040 |
Why?
|
| Tritium | 4 | 1995 | 707 | 0.040 |
Why?
|
| Mononuclear Phagocyte System | 2 | 1990 | 55 | 0.040 |
Why?
|
| E2F Transcription Factors | 1 | 2001 | 270 | 0.040 |
Why?
|
| DNA Fragmentation | 1 | 2000 | 239 | 0.040 |
Why?
|
| Lung Diseases | 1 | 2010 | 1944 | 0.040 |
Why?
|
| Adenoma, Acidophil | 1 | 1979 | 2 | 0.040 |
Why?
|
| CHO Cells | 1 | 2002 | 1377 | 0.040 |
Why?
|
| Lipid Peroxidation | 1 | 2000 | 276 | 0.040 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2005 | 584 | 0.040 |
Why?
|
| Bromocriptine | 1 | 1979 | 93 | 0.040 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2001 | 222 | 0.040 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2000 | 281 | 0.040 |
Why?
|
| Fetus | 1 | 1987 | 1884 | 0.040 |
Why?
|
| Fat Emulsions, Intravenous | 3 | 1992 | 314 | 0.040 |
Why?
|
| Blood Glucose | 7 | 2013 | 6429 | 0.040 |
Why?
|
| Age Factors | 1 | 2016 | 18406 | 0.040 |
Why?
|
| Cricetinae | 1 | 2002 | 2419 | 0.040 |
Why?
|
| Laparoscopy | 1 | 2010 | 2042 | 0.040 |
Why?
|
| Enteral Nutrition | 3 | 1989 | 802 | 0.040 |
Why?
|
| Informed Consent | 1 | 2005 | 1010 | 0.040 |
Why?
|
| Endothelium, Vascular | 2 | 2008 | 4427 | 0.040 |
Why?
|
| DNA, Neoplasm | 2 | 1994 | 1741 | 0.040 |
Why?
|
| Ovary | 1 | 2002 | 965 | 0.040 |
Why?
|
| Adipokines | 1 | 2019 | 309 | 0.040 |
Why?
|
| Immunoblotting | 1 | 2001 | 1647 | 0.040 |
Why?
|
| Amino Acids, Branched-Chain | 2 | 1992 | 267 | 0.040 |
Why?
|
| Parenteral Nutrition | 2 | 1995 | 663 | 0.040 |
Why?
|
| Body Composition | 2 | 2019 | 2462 | 0.040 |
Why?
|
| Protein Subunits | 1 | 2001 | 942 | 0.040 |
Why?
|
| Gastrectomy | 1 | 2022 | 693 | 0.030 |
Why?
|
| Cytokines | 1 | 1992 | 7451 | 0.030 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 1995 | 1942 | 0.030 |
Why?
|
| Deoxyglucose | 2 | 1995 | 333 | 0.030 |
Why?
|
| Models, Biological | 5 | 1994 | 9487 | 0.030 |
Why?
|
| Length of Stay | 1 | 2010 | 6489 | 0.030 |
Why?
|
| Cell Count | 1 | 2000 | 1825 | 0.030 |
Why?
|
| Fatty Acids | 3 | 2000 | 1809 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2002 | 3074 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2012 | 8633 | 0.030 |
Why?
|
| Acromegaly | 1 | 1979 | 317 | 0.030 |
Why?
|
| Rats, Inbred F344 | 2 | 1994 | 820 | 0.030 |
Why?
|
| Protein Biosynthesis | 5 | 1992 | 2093 | 0.030 |
Why?
|
| Inflammation | 2 | 2013 | 10875 | 0.030 |
Why?
|
| Comorbidity | 1 | 2010 | 10590 | 0.030 |
Why?
|
| Serine Endopeptidases | 1 | 2001 | 1027 | 0.030 |
Why?
|
| Absorption | 3 | 1983 | 244 | 0.030 |
Why?
|
| Drug Synergism | 2 | 2009 | 1760 | 0.030 |
Why?
|
| Energy Metabolism | 6 | 1995 | 2908 | 0.030 |
Why?
|
| Young Adult | 1 | 2021 | 60040 | 0.030 |
Why?
|
| Patient Education as Topic | 1 | 2005 | 2337 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2000 | 1405 | 0.030 |
Why?
|
| Receptors, Interleukin-1 | 1 | 1995 | 260 | 0.030 |
Why?
|
| Mitotic Index | 1 | 1994 | 160 | 0.030 |
Why?
|
| Intestinal Absorption | 3 | 1983 | 400 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 1995 | 1533 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2002 | 2877 | 0.030 |
Why?
|
| Nutritive Value | 4 | 1983 | 351 | 0.030 |
Why?
|
| Plant Oils | 2 | 1995 | 199 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2009 | 10461 | 0.030 |
Why?
|
| Liver Neoplasms | 1 | 2009 | 4358 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2000 | 3806 | 0.030 |
Why?
|
| Endothelins | 1 | 1993 | 127 | 0.030 |
Why?
|
| Prevalence | 1 | 2010 | 15862 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2000 | 2936 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2000 | 5022 | 0.030 |
Why?
|
| Carcinosarcoma | 1 | 1993 | 108 | 0.030 |
Why?
|
| Thromboxane A2 | 1 | 1992 | 87 | 0.030 |
Why?
|
| Radioisotope Dilution Technique | 2 | 1991 | 71 | 0.030 |
Why?
|
| Random Allocation | 3 | 1995 | 2394 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2010 | 5885 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 1994 | 1378 | 0.020 |
Why?
|
| Zinc Isotopes | 4 | 1983 | 6 | 0.020 |
Why?
|
| History, 21st Century | 1 | 2017 | 1572 | 0.020 |
Why?
|
| Meat | 3 | 1983 | 588 | 0.020 |
Why?
|
| Nutrition Disorders | 1 | 1992 | 204 | 0.020 |
Why?
|
| Floxuridine | 1 | 1991 | 44 | 0.020 |
Why?
|
| Antiporters | 1 | 1992 | 276 | 0.020 |
Why?
|
| Propidium | 1 | 1991 | 42 | 0.020 |
Why?
|
| Feces | 5 | 1983 | 1510 | 0.020 |
Why?
|
| Hemodynamics | 2 | 2013 | 4195 | 0.020 |
Why?
|
| Pituitary Neoplasms | 1 | 1979 | 1322 | 0.020 |
Why?
|
| G2 Phase | 1 | 1991 | 134 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 1993 | 13650 | 0.020 |
Why?
|
| C-Peptide | 1 | 1992 | 443 | 0.020 |
Why?
|
| Systole | 1 | 1992 | 937 | 0.020 |
Why?
|
| Cardiac Output | 1 | 1992 | 838 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2001 | 8314 | 0.020 |
Why?
|
| Litter Size | 1 | 1989 | 49 | 0.020 |
Why?
|
| History, 20th Century | 1 | 2017 | 2764 | 0.020 |
Why?
|
| Diastole | 1 | 1992 | 785 | 0.020 |
Why?
|
| Life Style | 1 | 2021 | 3932 | 0.020 |
Why?
|
| Energy Intake | 4 | 1989 | 2146 | 0.020 |
Why?
|
| Gestational Age | 2 | 1989 | 3622 | 0.020 |
Why?
|
| Anthropometry | 1 | 2013 | 1346 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2002 | 7613 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2019 | 5316 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2000 | 4524 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2022 | 65350 | 0.020 |
Why?
|
| Arginine | 1 | 1992 | 933 | 0.020 |
Why?
|
| Burns | 2 | 1989 | 1902 | 0.020 |
Why?
|
| Neoplasms, Experimental | 1 | 1992 | 1229 | 0.020 |
Why?
|
| Acute Disease | 1 | 2017 | 7237 | 0.020 |
Why?
|
| Lactic Acid | 1 | 1992 | 1140 | 0.020 |
Why?
|
| Peritoneal Neoplasms | 1 | 1993 | 706 | 0.020 |
Why?
|
| Neutron Activation Analysis | 2 | 1983 | 35 | 0.020 |
Why?
|
| Iron | 3 | 1983 | 1813 | 0.020 |
Why?
|
| Waist-Hip Ratio | 1 | 2008 | 520 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2019 | 8738 | 0.020 |
Why?
|
| Models, Theoretical | 2 | 1989 | 3573 | 0.020 |
Why?
|
| Milk Proteins | 2 | 1983 | 161 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2001 | 19002 | 0.020 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2008 | 392 | 0.020 |
Why?
|
| Delayed-Action Preparations | 1 | 1989 | 968 | 0.020 |
Why?
|
| MEDLINE | 1 | 2005 | 119 | 0.010 |
Why?
|
| Posture | 1 | 1989 | 957 | 0.010 |
Why?
|
| Erythrocytes | 2 | 1992 | 2411 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2001 | 5694 | 0.010 |
Why?
|
| Egg Proteins | 1 | 1983 | 58 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 2008 | 1378 | 0.010 |
Why?
|
| Pulsatile Flow | 1 | 2005 | 320 | 0.010 |
Why?
|
| Nitroglycerin | 1 | 2005 | 332 | 0.010 |
Why?
|
| Neoplasms | 1 | 1992 | 22353 | 0.010 |
Why?
|
| Aged | 4 | 2012 | 171439 | 0.010 |
Why?
|
| Patient Compliance | 1 | 2013 | 2697 | 0.010 |
Why?
|
| Recombinant Proteins | 4 | 1995 | 6515 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1987 | 2298 | 0.010 |
Why?
|
| Amino Acids | 1 | 1988 | 1713 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2007 | 15661 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2001 | 12162 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 1995 | 4976 | 0.010 |
Why?
|
| Nitrates | 1 | 1981 | 260 | 0.010 |
Why?
|
| Selenium | 1 | 1983 | 418 | 0.010 |
Why?
|
| Physical Fitness | 1 | 1983 | 744 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2000 | 23634 | 0.010 |
Why?
|
| Cell Line | 1 | 1991 | 15580 | 0.010 |
Why?
|
| Pregnancy | 2 | 1989 | 30249 | 0.010 |
Why?
|
| Helianthus | 1 | 1995 | 10 | 0.010 |
Why?
|
| Respiration | 2 | 1995 | 1661 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 1989 | 12463 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2008 | 12073 | 0.010 |
Why?
|
| United States | 1 | 2022 | 72987 | 0.010 |
Why?
|
| Sex Factors | 1 | 2008 | 10630 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 1991 | 6360 | 0.010 |
Why?
|
| Organ Size | 2 | 1990 | 2268 | 0.010 |
Why?
|
| Adolescent | 3 | 1989 | 89098 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1993 | 861 | 0.010 |
Why?
|
| Evidence-Based Medicine | 1 | 2005 | 3699 | 0.010 |
Why?
|
| Oxygen Consumption | 2 | 1989 | 1883 | 0.010 |
Why?
|
| Calorimetry, Indirect | 1 | 1993 | 177 | 0.010 |
Why?
|
| Emulsions | 1 | 1992 | 150 | 0.010 |
Why?
|
| Soybean Oil | 1 | 1992 | 139 | 0.010 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 1991 | 58 | 0.010 |
Why?
|
| Hormones | 1 | 1995 | 866 | 0.010 |
Why?
|
| Chickens | 2 | 1983 | 843 | 0.010 |
Why?
|
| Infusions, Parenteral | 1 | 1990 | 395 | 0.010 |
Why?
|
| Hyperinsulinism | 1 | 1993 | 402 | 0.010 |
Why?
|
| Metabolic Clearance Rate | 1 | 1990 | 363 | 0.010 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 1991 | 225 | 0.010 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 1991 | 394 | 0.010 |
Why?
|
| Diet, Reducing | 1 | 1992 | 487 | 0.000 |
Why?
|
| Phospholipids | 1 | 1992 | 779 | 0.000 |
Why?
|
| Blood Urea Nitrogen | 1 | 1988 | 189 | 0.000 |
Why?
|
| Glucagon | 1 | 1990 | 534 | 0.000 |
Why?
|
| Regional Blood Flow | 1 | 1991 | 1499 | 0.000 |
Why?
|
| Gluconeogenesis | 1 | 1988 | 186 | 0.000 |
Why?
|
| Caseins | 1 | 1986 | 105 | 0.000 |
Why?
|
| Selenious Acid | 1 | 1983 | 6 | 0.000 |
Why?
|
| Isotopes | 1 | 1983 | 125 | 0.000 |
Why?
|
| Reference Values | 1 | 1990 | 4936 | 0.000 |
Why?
|
| RNA | 1 | 1992 | 2717 | 0.000 |
Why?
|
| Prospective Studies | 1 | 2005 | 54915 | 0.000 |
Why?
|
| Gamma Rays | 1 | 1981 | 324 | 0.000 |
Why?
|
| Plasma | 1 | 1981 | 583 | 0.000 |
Why?
|
| Cattle | 1 | 1982 | 3816 | 0.000 |
Why?
|
| Aged, 80 and over | 2 | 1990 | 59594 | 0.000 |
Why?
|
| Cohort Studies | 1 | 1992 | 41743 | 0.000 |
Why?
|
| Algorithms | 1 | 1988 | 14174 | 0.000 |
Why?
|
Concepts
(338)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(7)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_